SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global dextrose injection market is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% ...

Amphastar Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Dextrose injection 50% in the 50 ml Luer-Jet Prefilled ...

Hikma is offering labetalol hydrochloride 1mg/mL in 200-ml dextrose injection and 100-, 200- and 300-mL in sodium chloride injection. Labetalol HCl in sodium chloride injection and labetalol HCl in ...

New clinical data suggests intra-articular injections of hypertonic dextrose are safe and effective at alleviating knee pain caused by osteoarthritis, a condition affecting nearly 30 million Americans ...

RANCHO CUCAMONGA, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s ...

Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use formulations to ...

Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for the ...

SterRx, LLC today announced the voluntary nationwide recall of three lots of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL due to waterborne microbial contamination. SterRx, LLC has ...

After Baxter International temporarily closed its North Cove facility in Marion, N.C., the company told customers in an Oct. 3 email to evaluate their inventory of several saline, dextrose and ...